30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Revance Therapeutics Inc (RVNC)

Track

Stock chart
Ticker: RVNC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hollander David
CMO & Global Therapeutics Lead
1 sale — total 16,296 USD
Sale 18 Nov 2024
Value US$2,660,279.77 | Price 99.75 | Shares 66,215
Sale 16 Apr 2024
Value US$4,529,634.89 | Price 139.77 | Shares 44,421
Sale 18 Mar 2024
Value US$40,971.12 | Price 5.04 | Shares 8,125
Sale 18 Mar 2024
Value US$47,203.78 | Price 5.04 | Shares 9,361
Sale 18 Mar 2024
Value US$46,446.47 | Price 5.04 | Shares 9,211
Proposed sale 15 Mar 2024
Value US$52,500.00 | Price 5.53 | Shares 9,500
Proposed sale 15 Mar 2024
Value US$52,500.00 | Price 5.53 | Shares 9,500
Proposed sale 15 Mar 2024
Value US$46,750.00 | Price 5.50 | Shares 8,500
Buy 6 Mar 2024
Value US$209,400.00 | Price 6.98 | Shares 30,000
Planned sale 6 Sep 2023
Value US$187,704.00 | Price 17.06 | Shares 11,000
Proposed sale 6 Sep 2023
Value US$187,704.00 | Price 17.06 | Shares 11,000
Planned sale 5 Sep 2023
Value US$424,919.73 | Price 17.81 | Shares 23,853
Proposed sale 5 Sep 2023
Value US$424,917.34 | Price 17.81 | Shares 23,853
Planned sale 3 Aug 2023
Value US$593,151.19 | Price 22.57 | Shares 26,279
Proposed sale 3 Aug 2023
Value US$591,114.57 | Price 22.49 | Shares 26,279
Planned sale 3 Jul 2023
Value US$42,593.04 | Price 25.04 | Shares 1,701
Planned sale 3 Jul 2023
Value US$655,332.56 | Price 24.94 | Shares 26,279
Proposed sale 3 Jul 2023
Value US$655,398.26 | Price 24.94 | Shares 26,279
Proposed sale 3 Jul 2023
Value US$42,593.04 | Price 25.04 | Shares 1,701
Planned sale 15 Jun 2023
Value US$70,600.00 | Price 28.24 | Shares 2,500
Proposed sale 15 Jun 2023
Value US$70,600.00 | Price 28.24 | Shares 2,500
Planned sale 9 Jun 2023
Value US$960,928.41 | Price 30.72 | Shares 31,279
Planned sale 9 Jun 2023
Value US$154,096.00 | Price 30.82 | Shares 5,000
Proposed sale 9 Jun 2023
Value US$154,095.99 | Price 30.82 | Shares 5,000
Proposed sale 9 Jun 2023
Value US$960,901.30 | Price 30.72 | Shares 31,279
Planned sale 2 Jun 2023
Value US$15,500.00 | Price 31.00 | Shares 500
Proposed sale 2 Jun 2023
Value US$15,500.00 | Price 31.00 | Shares 500
Planned sale 1 Jun 2023
Value US$82,569.57 | Price 30.57 | Shares 2,701
Proposed sale 1 Jun 2023
Value US$82,569.57 | Price 30.57 | Shares 2,701
Sale 15 May 2023
Value US$739,338.21 | Price 34.55 | Shares 21,401
Sale 15 May 2023
Value US$739,338.21 | Price 34.55 | Shares 21,401
Sale 15 May 2023
Value US$726,003.10 | Price 34.55 | Shares 21,015
Sale 15 May 2023
Value US$2,433,725.46 | Price 34.55 | Shares 70,447
Proposed sale 15 May 2023
Value US$15,450.00 | Price 34.56 | Shares 447
Proposed sale 12 May 2023
Value US$734,800.00 | Price 33.40 | Shares 22,000
Proposed sale 12 May 2023
Value US$734,800.00 | Price 33.40 | Shares 22,000
Proposed sale 12 May 2023
Value US$734,800.00 | Price 33.40 | Shares 22,000
Proposed sale 12 May 2023
Value US$2,338,000.00 | Price 33.40 | Shares 70,000
Planned sale 1 May 2023
Value US$101,471.70 | Price 31.70 | Shares 3,201
Proposed sale 1 May 2023
Value US$101,471.70 | Price 31.70 | Shares 3,201
Planned sale 3 Apr 2023
Value US$102,912.15 | Price 32.15 | Shares 3,201
Sale 9 Mar 2023
Value US$2,223,359.66 | Price 31.59 | Shares 70,390
Sale 9 Mar 2023
Value US$584,220.20 | Price 31.59 | Shares 18,496
Sale 9 Mar 2023
Value US$679,358.14 | Price 31.59 | Shares 21,508
Sale 9 Mar 2023
Value US$584,883.52 | Price 31.59 | Shares 18,517
Proposed sale 8 Mar 2023
Value US$660,000.00 | Price 33.00 | Shares 20,000
Proposed sale 8 Mar 2023
Value US$660,000.00 | Price 33.00 | Shares 20,000
Proposed sale 8 Mar 2023
Value US$2,475,000.00 | Price 33.00 | Shares 75,000
Proposed sale 8 Mar 2023
Value US$759,000.00 | Price 33.00 | Shares 23,000
Planned sale 1 Mar 2023
Value US$107,233.50 | Price 33.50 | Shares 3,201
Planned sale 1 Feb 2023
Value US$110,754.60 | Price 34.60 | Shares 3,201
Planned sale 20 Jan 2023
Value US$31,000.00 | Price 31.00 | Shares 1,000
Planned sale 9 Jan 2023
Value US$30,000.00 | Price 30.00 | Shares 1,000
Planned sale 9 Jan 2023
Value US$28,000.00 | Price 28.00 | Shares 1,000
Planned sale 9 Jan 2023
Value US$42,525.00 | Price 25.00 | Shares 1,701
Planned sale 14 Sep 2022
Value US$297,797.50 | Price 27.07 | Shares 11,000
Buy 13 Dec 2021
Value US$100,741.12 | Price 15.74 | Shares 6,400
Buy 3 Dec 2021
Value US$432,876.00 | Price 14.43 | Shares 30,000
Buy 29 Nov 2021
Value US$515,924.00 | Price 12.90 | Shares 40,000
Planned sale 27 Sep 2021
Value US$50,250.00 | Price 30.00 | Shares 1,675
Planned sale 5 Apr 2021
Value US$56.56 | Price 28.28 | Shares 2
Planned sale 4 Mar 2021
Value US$842,216.17 | Price 25.43 | Shares 33,119
Planned sale 1 Feb 2021
Value US$859,438.05 | Price 25.95 | Shares 33,119
Planned sale 30 Dec 2020
Value US$921,211.61 | Price 27.82 | Shares 33,119
Planned sale 30 Nov 2020
Value US$789,888.15 | Price 23.85 | Shares 33,119
Planned sale 29 Oct 2020
Value US$865,949.25 | Price 26.15 | Shares 33,119
Planned sale 18 Mar 2019
Value US$180,067.69 | Price 15.51 | Shares 11,613
Planned sale 18 Mar 2019
Value US$7,709.04 | Price 15.48 | Shares 498
Planned sale 19 Feb 2019
Value US$96,285.28 | Price 17.68 | Shares 5,446
Planned sale 22 Jan 2019
Value US$11,106.25 | Price 17.77 | Shares 625
Planned sale 3 Jan 2019
Value US$7,305.00 | Price 19.48 | Shares 375
Planned sale 20 Nov 2018
Value US$10,144.06 | Price 20.66 | Shares 491
Planned sale 9 Nov 2018
Value US$51,899.36 | Price 23.72 | Shares 2,188
Planned sale 6 Jul 2018
Value US$11,141.55 | Price 28.35 | Shares 393
Planned sale 22 May 2018
Value US$86,924.42 | Price 30.25 | Shares 2,874
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-19 2024-11-18 S Sale
Hollander David

CMO & Global Therapeutics Lead

Officer
66,215 +11.2%
99.75
US$2,660,280 		66,215 +11.2% 99.75 US$2,660,280
2024-04-17 2024-04-16 S Sale
1.7
Jordan Erica

Chief Commercial Officer

Officer
44,421 +33.8%
139.77
US$4,529,635 		44,421 +33.8% 139.77 US$4,529,635
2024-03-19 2024-03-18 S Sale
3.8
Moxie Dwight

CLO & GC

Officer
74,461 -18.5%
415.28
US$92,020 		74,461 -18.5% 415.28 US$92,020
2024-03-19 2024-03-18 S Sale
3.8
Schilke Tobin

CFO

Officer
9,361 -4.6%
5.04
US$47,204 		9,361 -4.6% 5.04 US$47,204
2024-03-19 2024-03-18 S Sale
3.7
Sjuts Dustin S

President

Officer
9,211 -5.2%
5.04
US$46,446 		9,211 -5.2% 5.04 US$46,446
2024-03-18 2024-03-15 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
9,500
5.53
US$52,500 		9,500 5.53 US$52,500
2024-03-18 2024-03-15 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
9,500
5.53
US$52,500 		9,500 5.53 US$52,500
2024-03-18 2024-03-15 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
8,500
5.50
US$46,750 		8,500 5.50 US$46,750
2024-03-08 2024-03-06 B Purchase
3.5
Foley Mark J

CEO

Executive Director
30,000 +3.0%
6.98
US$209,400 		30,000 +3.0% 6.98 US$209,400
2023-09-07 2023-09-06 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
11,000 -20.0%
17.06
US$187,704 		11,000 -20.0% 17.06 US$187,704
2023-09-06 2023-09-06 PrS Proposed sale
3.8
DWIGHT MOXIE

Officer

Officer
11,000
17.06
US$187,704 		11,000 17.06 US$187,704
2023-09-07 2023-09-05 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
23,853 -30.2%
17.81
US$424,920 		23,853 -30.2% 17.81 US$424,920
2023-09-05 2023-09-05 PrS Proposed sale
3.8
DWIGHT MOXIE

Officer

Officer
23,853
17.81
US$424,917 		23,853 17.81 US$424,917
2023-08-04 2023-08-03 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
26,279 -3.0%
22.57
US$593,151 		26,279 -3.0% 22.57 US$593,151
2023-08-03 2023-08-03 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
26,279
22.49
US$591,115 		26,279 22.49 US$591,115
2023-07-05 2023-07-03 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,701 -2.1%
25.04
US$42,593 		1,701 -2.1% 25.04 US$42,593
2023-07-05 2023-07-03 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
26,279 -2.9%
24.94
US$655,333 		26,279 -2.9% 24.94 US$655,333
2023-07-03 2023-07-03 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
26,279
24.94
US$655,398 		26,279 24.94 US$655,398
2023-07-03 2023-07-03 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
1,701
25.04
US$42,593 		1,701 25.04 US$42,593
2023-06-20 2023-06-15 PlS Planned sale
Kolaja Carey OConnor
Non-Executive Director
2,500 -13.1%
28.24
US$70,600 		2,500 -13.1% 28.24 US$70,600
2023-06-15 2023-06-15 PrS Proposed sale
CAREY KOLAJA

Director

Non-Executive Director
2,500
28.24
US$70,600 		2,500 28.24 US$70,600
2023-06-13 2023-06-09 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
31,279 -3.4%
30.72
US$960,928 		31,279 -3.4% 30.72 US$960,928
2023-06-13 2023-06-09 PlS Planned sale
3.7
Sjuts Dustin S

President

Officer
5,000 -3.3%
30.82
US$154,096 		5,000 -3.3% 30.82 US$154,096
2023-06-09 2023-06-09 PrS Proposed sale
3.7
DUSTIN SJUTS

Officer

Officer
5,000
30.82
US$154,096 		5,000 30.82 US$154,096
2023-06-09 2023-06-09 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
31,279
30.72
US$960,901 		31,279 30.72 US$960,901
2023-06-05 2023-06-02 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
500 -0.6%
31.00
US$15,500 		500 -0.6% 31.00 US$15,500
2023-06-02 2023-06-02 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
500
31.00
US$15,500 		500 31.00 US$15,500
2023-06-05 2023-06-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
2,701 -3.2%
30.57
US$82,570 		2,701 -3.2% 30.57 US$82,570
2023-06-01 2023-06-01 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
2,701
30.57
US$82,570 		2,701 30.57 US$82,570
2023-05-16 2023-05-15 S Sale
3.8
Schilke Tobin

CFO

Officer
21,401 -20.3%
34.55
US$739,338 		21,401 -20.3% 34.55 US$739,338
2023-05-16 2023-05-15 S Sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
21,401 -23.6%
34.55
US$739,338 		21,401 -23.6% 34.55 US$739,338
2023-05-16 2023-05-15 S Sale
3.7
Sjuts Dustin S

President

Officer
21,015 -12.1%
34.55
US$726,003 		21,015 -12.1% 34.55 US$726,003
2023-05-16 2023-05-15 S Sale
3.5
Foley Mark J

CEO

Executive Director
70,447 -7.1%
34.55
US$2,433,725 		70,447 -7.1% 34.55 US$2,433,725
2023-05-15 2023-05-15 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
447
34.56
US$15,450 		447 34.56 US$15,450
2023-05-12 2023-05-12 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
70,000
33.40
US$2,338,000 		70,000 33.40 US$2,338,000
2023-05-02 2023-05-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -4.8%
31.70
US$101,472 		3,201 -4.8% 31.70 US$101,472
2023-05-01 2023-05-01 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
3,201
31.70
US$101,472 		3,201 31.70 US$101,472
2023-04-04 2023-04-03 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -4.6%
32.15
US$102,912 		3,201 -4.6% 32.15 US$102,912
2023-03-09 2023-03-09 S Sale
3.5
Foley Mark J

CEO

Executive Director
70,390 -7.9%
31.59
US$2,223,360 		70,390 -7.9% 31.59 US$2,223,360
2023-03-09 2023-03-09 S Sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
18,496 -25.0%
31.59
US$584,220 		18,496 -25.0% 31.59 US$584,220
2023-03-09 2023-03-09 S Sale
3.7
Sjuts Dustin S

President

Officer
21,508 -14.8%
31.59
US$679,358 		21,508 -14.8% 31.59 US$679,358
2023-03-09 2023-03-09 S Sale
3.8
Schilke Tobin

CFO

Officer
18,517 -20.2%
31.59
US$584,884 		18,517 -20.2% 31.59 US$584,884
2023-03-09 2023-03-08 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
20,000
33.00
US$660,000 		20,000 33.00 US$660,000
2023-03-09 2023-03-08 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
20,000
33.00
US$660,000 		20,000 33.00 US$660,000
2023-03-09 2023-03-08 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
75,000
33.00
US$2,475,000 		75,000 33.00 US$2,475,000
2023-03-09 2023-03-08 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
23,000
33.00
US$759,000 		23,000 33.00 US$759,000
2023-03-02 2023-03-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -6.1%
33.50
US$107,234 		3,201 -6.1% 33.50 US$107,234
2023-02-02 2023-02-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -5.5%
34.60
US$110,755 		3,201 -5.5% 34.60 US$110,755
2023-01-23 2023-01-20 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.7%
31.00
US$31,000 		1,000 -1.7% 31.00 US$31,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.7%
30.00
US$30,000 		1,000 -1.7% 30.00 US$30,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.6%
28.00
US$28,000 		1,000 -1.6% 28.00 US$28,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,701 -2.7%
25.00
US$42,525 		1,701 -2.7% 25.00 US$42,525
2022-09-16 2022-09-14 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
11,000 -25.8%
27.07
US$297,798 		11,000 -25.8% 27.07 US$297,798
2021-12-15 2021-12-13 B Purchase
1.4
Russell Angus C.
Non-Executive Director
6,400 +31.2%
15.74
US$100,741 		6,400 +31.2% 15.74 US$100,741
2021-12-06 2021-12-03 B Purchase
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
30,000 +45.8%
14.43
US$432,876 		30,000 +45.8% 14.43 US$432,876
2021-11-29 2021-11-29 B Purchase
3.5
Foley Mark J

CEO

Executive Director
40,000 +56.4%
12.90
US$515,924 		40,000 +56.4% 12.90 US$515,924
2021-09-28 2021-09-27 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
1,675 -3.4%
30.00
US$50,250 		1,675 -3.4% 30.00 US$50,250
2021-04-06 2021-04-05 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
2 -0.0%
28.28
US$57 		2 -0.0% 28.28 US$57
2021-03-05 2021-03-04 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -7.5%
25.43
US$842,216 		33,119 -7.5% 25.43 US$842,216
2021-02-03 2021-02-01 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.9%
25.95
US$859,438 		33,119 -6.9% 25.95 US$859,438
2021-01-04 2020-12-30 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.5%
27.82
US$921,212 		33,119 -6.5% 27.82 US$921,212
2020-12-02 2020-11-30 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.1%
23.85
US$789,888 		33,119 -6.1% 23.85 US$789,888
2020-10-30 2020-10-29 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -5.7%
26.15
US$865,949 		33,119 -5.7% 26.15 US$865,949
2019-03-19 2019-03-18 PlS Planned sale
Browne L Daniel

CEO and President

Executive Director
11,613 -7.1%
15.51
US$180,068 		11,613 -7.1% 15.51 US$180,068
2019-03-19 2019-03-18 PlS Planned sale
Allouche Cyril

Principal Accounting Officer
498 -7.2%
15.48
US$7,709 		498 -7.2% 15.48 US$7,709
2019-02-20 2019-02-19 PlS Planned sale
Browne L Daniel

CEO and President

Executive Director
5,446 -3.1%
17.68
US$96,285 		5,446 -3.1% 17.68 US$96,285
2019-01-23 2019-01-22 PlS Planned sale
Allouche Cyril

Principal Accounting Officer

Officer
625 -13.5%
17.77
US$11,106 		625 -13.5% 17.77 US$11,106
2019-01-04 2019-01-03 PlS Planned sale
Allouche Cyril

Principal Accounting Officer

Officer
375 -8.6%
19.48
US$7,305 		375 -8.6% 19.48 US$7,305
2018-11-21 2018-11-20 PlS Planned sale Allouche Cyril

Principal Accounting Officer

Officer
491 -10.9%
20.66
US$10,144 		491 -10.9% 20.66 US$10,144
2018-11-09 2018-11-09 PlS Planned sale Allouche Cyril

Principal Accounting Officer

Officer
2,188 -31.5%
23.72
US$51,899 		2,188 -31.5% 23.72 US$51,899
2018-07-06 2018-07-06 PlS Planned sale Allouche Cyril

Principal Financial Officer

Officer
393 -7.6%
28.35
US$11,142 		393 -7.6% 28.35 US$11,142
2018-05-24 2018-05-22 PlS Planned sale SILVERNAIL LAUREN P

CFO & CBO

Officer
2,874 -4.2%
30.25
US$86,924 		2,874 -4.2% 30.25 US$86,924
Explore more

More insider trading research around Revance Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America